Search Ontology:
ChEBI
gadoterate meglumine
- Term ID
- CHEBI:73727
- Synonyms
-
- 1-deoxy-1-(methylazaniumyl)-D-glucitol [2,2',2'',2'''-(1,4,7,10-tetraazacyclododecane-1,4,7,10-tetrayl-kappa(4)N(1),N(4),N(7),N(10))tetraacetato(4-)]gadolinate(1-)
- [2,2',2'',2'''-(1,4,7,10-tetraazacyclododecane-1,4,7,10-tetrayl-kappa(4)N(1),N(4),N(7),N(10))tetraacetato(3-)]gadolinium--1-deoxy-1-(methylamino)-D-glucitol (1/1)
- Gadolinium-DOTA meglumine
- Gd-DOTA meglumine
- Meglumine gadopentate
- Meglumine gadoterate
- Definition
- An organoammonium salt obtained by reaction of gadoteric acid with one equivalent of 1-deoxy-1-(methylamino)-D-glucitol (meglumine). It is used in magnetic resonance imaging (MRI) in brain (intracranial), spine and associated tissues of patients ages 2 years and older, to detect and visualise areas with disruption of the blood brain barrier and/or abnormal vascularity of the central nervous system.
- References
-
- cas:92943-93-6
- kegg.drug:D03355
- pubmed:20407903
- pubmed:21045181
- pubmed:21339348
- pubmed:21577130
- pubmed:21890295
- pubmed:21904991
- pubmed:22068227
- pubmed:22109336
- pubmed:22167518
- pubmed:22344402
- pubmed:22543971
- pubmed:22578838
- pubmed:22592612
- pubmed:22772150
- pubmed:23211552
- pubmed:23212275
- pubmed:23262793
- pubmed:23297321
- wikipedia.en:Gadoteric_acid
- Ontology
- ChEBI ( EBI )
Phenotype
Phenotype resulting from gadoterate meglumine
Phenotype where environments contain gadoterate meglumine
Phenotype modified by environments containing gadoterate meglumine
Phenotype affecting gadoterate meglumine
Human Disease Model